Genomics X Prize canceled: “Outpaced by innovation”

source varitety GEN

In an anticlimactic move, mere weeks before its official start, the genomics X Prize – intended to spur a revolution in fast, cheap and accurate human-genome sequencing – has been abruptly cancelled, because it was “outpaced by innovation.”

The prize challenged companies to design devices that could sequence 100 human genomes in 30 days or less, with additional requirements for accuracy and cost. Today, companies are routinely sequencing human genomes for less than the $10,000 per genome goal.

But the full picture is more complex. Yes, the cost of genome sequencing has plummeted, (the prize dropped its cost goal to $1000 per genome in response). But current technologies are still far from meeting the accuracy goal.

Read the full, original story here: X Prize for genomes cancelled before it begins

Additional Resources:

  • “Outpaced by Innovation: Canceling an XPRIZE,” Huffington Post
    Chairman and CEO of the X Prize Foundation, Peter Diamandis, explained the rationale for the cancelation in a Huffington Post column. 
  • “Tepid showing for genomics X prize,” Nature
    In May, Nature told the story of the sparse list of competition applicants and the difficulty of driving down the number of inaccuracies in a sequenced genome.

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
Crisp Physicians’ Protest Sign Close-Up
‘He’s a disgrace’: Some newly-elected legislators and health groups call for RFK Jr. impeachment 
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
ChatGPT-Image-Aug-18-2026-12_22_33-PM-2
‘The cure for measles is chicken soup and vitamin A’: Kennedy’s dangerous history of mocking vaccines
Split-Toned-Capitol-Healthcare-Rally
Viewpoint: Here’s how Congress can begin to reverse a two-year public health disinformation slide
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
Energetic Speaker on Stage
Viewpoint: Why are the stars of the MAHA revolution standing by convicted rapist — and conservative firebrand — Russell Brand?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.